Trials / Completed

CompletedNCT00002153

Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders

Status: Completed
Phase: Phase 1
Study type: Interventional
Enrollment: 25 (planned)

Sponsor: DEKK-TEC, Inc. · Industry
Sex: All
Age: 21 Years
Healthy volunteers: Not accepted

Summary

To evaluate topical A-007 in patients with advanced malignancies including Kaposi's sarcoma and lymphoproliferative disorders.

Conditions

Sarcoma, Kaposi
HIV Infections
Lymphoproliferative Disorders

Interventions

Type	Name	Description
DRUG	A-007

Timeline

First posted: 2001-08-31
Last updated: 2005-06-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00002153. Inclusion in this directory is not an endorsement.